跳至主要内容
临床试验/IRCT20200217046526N1
IRCT20200217046526N1已完成1 期

Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection : A Phase 1 and 2 clinical trial

Iranian academic center for education culture and research0 个研究点目标入组 6 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Informed consent
  • Male or female
  • 18-70 years old
  • ARDS diagnosed
  • SOFA score between 2-13 point
  • Requiring mechanical ventilation and/or supplemental oxygen
  • Pneumonia that is judged by chest radiograph or CT scan or confirmation of SARS-CoV-2 infection by qRT-PCR
  • PaO2/oxygen absorption concentration (FiO2) = 300 mmHG

排除标准

  • Presenting severe allergies after 1st injection of stem cell
  • Patients with a malignant tumor and psychosis
  • Co-Infection of HIV, tuberculosis, adenovirus and another respiratory infection virus
  • Patients with previous history of pulmonary embolism
  • Moribund patient expecting death within 48 hours
  • Continuous use of immunosuppressive agents or organ transplants in the past 6 months
  • Pregnancy or breastfeeding

研究者

发起方
Iranian academic center for education culture and research

相似试验